Endothelial impairment evaluation by peripheral arterial tonometry in pediatric endocrinopathies: A narrative review

Alberto La Valle1, Marco Crocco1, Decimo Silvio Chiarenza1

  • 1Pediatric Clinic and Endocrinology, IRCCS Istituto Giannina Gaslini, Genoa16147, Italy.

Insights

Endothelial dysfunction (ED) is a key indicator of cardiovascular risk in children and adolescents. Non-invasive techniques like reactive hyperemia-peripheral artery tonometry can detect early ED in pediatric endocrine diseases.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Non-invasive Diagnostics

Background:

  • Endothelial dysfunction (ED) involves an imbalance of vasoactive agents, increasing risks for microvascular and macrovascular complications.
  • ED is prevalent in pediatric conditions like type 1 and type 2 diabetes mellitus, obesity, metabolic syndrome, and pituitary dysfunction.
  • Emerging causes of ED include insulin resistance in cancer survivors and transplant recipients.

Purpose of the Study:

  • To review the literature on detecting endothelial dysfunction in children and adolescents with endocrine diseases.
  • To highlight the utility of non-invasive techniques for early ED detection.
  • To focus on the application of EndoPat 2000 in pediatric endocrine populations.

Main Methods:

  • Narrative review of English-language articles.
  • Searched MEDLINE database for studies published between 2005 and 2020.
  • Focused on papers detailing endothelial function assessment using EndoPat 2000.

Main Results:

  • Reactive hyperemia-peripheral artery tonometry (EndoPat 2000) is a non-invasive, reproducible method for assessing peripheral endothelial function.
  • This technique can detect early-stage endothelial dysfunction (ED) before clinical symptoms manifest.
  • The review synthesizes findings on ED detection in pediatric endocrine disease contexts.

Conclusions:

  • Early detection of ED using non-invasive methods like EndoPat 2000 is crucial for identifying at-risk pediatric patients.
  • Timely intervention can prevent the progression to more severe microangiopathic and macroangiopathic impairments.
  • EndoPat 2000 is a valuable tool for assessing endothelial function in children and adolescents with endocrine disorders.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
107
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
115
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
265
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
641
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
125
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
164